156 related articles for article (PubMed ID: 9973209)
1. 2-[C-11]thymidine imaging of malignant brain tumors.
Eary JF; Mankoff DA; Spence AM; Berger MS; Olshen A; Link JM; O'Sullivan F; Krohn KA
Cancer Res; 1999 Feb; 59(3):615-21. PubMed ID: 9973209
[TBL] [Abstract][Full Text] [Related]
2. Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas.
Muzi M; Spence AM; O'Sullivan F; Mankoff DA; Wells JM; Grierson JR; Link JM; Krohn KA
J Nucl Med; 2006 Oct; 47(10):1612-21. PubMed ID: 17015896
[TBL] [Abstract][Full Text] [Related]
3. [Methyl-11C]thymidine positron emission tomography in tumoral and non-tumoral cerebral lesions.
De Reuck J; Santens P; Goethals P; Strijckmans K; Lemahieu I; Boon P; Achten E; Lemmerling M; Vandekerckhove T; Caemaert J
Acta Neurol Belg; 1999 Jun; 99(2):118-25. PubMed ID: 10427354
[TBL] [Abstract][Full Text] [Related]
4. Kinetic analysis of 2-[11C]thymidine PET imaging studies: validation studies.
Mankoff DA; Shields AF; Link JM; Graham MM; Muzi M; Peterson LM; Eary JF; Krohn KA
J Nucl Med; 1999 Apr; 40(4):614-24. PubMed ID: 10210220
[TBL] [Abstract][Full Text] [Related]
5. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
Valk PE; Budinger TF; Levin VA; Silver P; Gutin PH; Doyle WK
J Neurosurg; 1988 Dec; 69(6):830-8. PubMed ID: 2848111
[TBL] [Abstract][Full Text] [Related]
6. Kinetic analysis of 2-[11C]thymidine PET imaging studies of malignant brain tumors: preliminary patient results.
Wells JM; Mankoff DA; Eary JF; Spence AM; Muzi M; O'Sullivan F; Vernon CB; Link JM; Krohn KA
Mol Imaging; 2002 Jul; 1(3):145-50. PubMed ID: 12920852
[TBL] [Abstract][Full Text] [Related]
7. The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas.
Gross MW; Weber WA; Feldmann HJ; Bartenstein P; Schwaiger M; Molls M
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):989-95. PubMed ID: 9719107
[TBL] [Abstract][Full Text] [Related]
8. [Value of 18F-FDG and 11C-MET PET-CT in differentiation of brain ringlike-enhanced neoplastic and non-neoplastic lesions on MRI imaging].
Cai L; Gao S; Li DC; Li YS; Chen QS; Xing XL
Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):134-8. PubMed ID: 19538892
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of 4'-[methyl-14C]thiothymidine for in vivo DNA synthesis imaging.
Toyohara J; Kumata K; Fukushi K; Irie T; Suzuki K
J Nucl Med; 2006 Oct; 47(10):1717-22. PubMed ID: 17015909
[TBL] [Abstract][Full Text] [Related]
10. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
Weber W; Bartenstein P; Gross MW; Kinzel D; Daschner H; Feldmann HJ; Reidel G; Ziegler SI; Lumenta C; Molls M; Schwaiger M
J Nucl Med; 1997 May; 38(5):802-8. PubMed ID: 9170450
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography imaging of brain tumors.
Wong TZ; van der Westhuizen GJ; Coleman RE
Neuroimaging Clin N Am; 2002 Nov; 12(4):615-26. PubMed ID: 12687915
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone treatment and plasma glucose levels: relevance for fluorine-18-fluorodeoxyglucose uptake measurements in gliomas.
Roelcke U; Blasberg RG; von Ammon K; Hofer S; Vontobel P; Maguire RP; Radü EW; Herrmann R; Leenders KL
J Nucl Med; 1998 May; 39(5):879-84. PubMed ID: 9591593
[TBL] [Abstract][Full Text] [Related]
13. Molecular imaging (PET) of brain tumors.
Basu S; Alavi A
Neuroimaging Clin N Am; 2009 Nov; 19(4):625-46. PubMed ID: 19959009
[TBL] [Abstract][Full Text] [Related]
14. Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine.
Dupertuis YM; Vazquez M; Mach JP; De Tribolet N; Pichard C; Slosman DO; Buchegger F
Cancer Res; 2001 Nov; 61(21):7971-7. PubMed ID: 11691821
[TBL] [Abstract][Full Text] [Related]
15. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma.
Barker FG; Chang SM; Valk PE; Pounds TR; Prados MD
Cancer; 1997 Jan; 79(1):115-26. PubMed ID: 8988735
[TBL] [Abstract][Full Text] [Related]
16. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
[TBL] [Abstract][Full Text] [Related]
17. Carbon-11-thymidine and FDG to measure therapy response.
Shields AF; Mankoff DA; Link JM; Graham MM; Eary JF; Kozawa SM; Zheng M; Lewellen B; Lewellen TK; Grierson JR; Krohn KA
J Nucl Med; 1998 Oct; 39(10):1757-62. PubMed ID: 9776283
[TBL] [Abstract][Full Text] [Related]
18. Optimization of the reference region method for dual pharmacokinetic modeling using Gd-DTPA/MRI and (18) F-FDG/PET.
Poulin É; Lebel R; Croteau É; Blanchette M; Tremblay L; Lecomte R; Bentourkia M; Lepage M
Magn Reson Med; 2015 Feb; 73(2):740-8. PubMed ID: 24604379
[TBL] [Abstract][Full Text] [Related]
19. Measurement of the extracellular space in brain tumors using 76Br-bromide and PET.
Bruehlmeier M; Roelcke U; Bläuenstein P; Missimer J; Schubiger PA; Locher JT; Pellikka R; Ametamey SM
J Nucl Med; 2003 Aug; 44(8):1210-8. PubMed ID: 12902409
[TBL] [Abstract][Full Text] [Related]
20. Brain tumor imaging with PET and 2-[carbon-11]thymidine.
Vander Borght T; Pauwels S; Lambotte L; Labar D; De Maeght S; Stroobandt G; Laterre C
J Nucl Med; 1994 Jun; 35(6):974-82. PubMed ID: 8195884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]